Navigation Links
TAXUS(R) Liberte(R) Stent Continues to Demonstrate Significant Improvements Over TAXUS(R) Express(R) Stent in Small Vessels and Long Lesions
Date:9/22/2009

NATICK, Mass. and SAN FRANCISCO, Sept. 22 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, single-arm trials evaluating the TAXUS((R)) Liberte((R)) Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. Three-year results from the TAXUS ATLAS Small Vessel and Long Lesion Trials continue to show significant advantages for the newer TAXUS Liberte Stent when compared to the first-generation TAXUS((R)) Express((R)) Stent. The data were presented at the 21(st) annual Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in San Francisco.

The TAXUS ATLAS Small Vessel Trial was designed to evaluate the long-term safety and efficacy of the 2.25 mm diameter TAXUS((R)) Liberte((R))( )Atom((TM)) Stent in small coronary vessels. The TAXUS ATLAS Long Lesion Trial was designed to assess the long-term safety and efficacy of the TAXUS((R)) Liberte((R)) Long 38 mm Stent in patients with long coronary lesions. Boston Scientific remains the only company to offer both 2.25 mm diameter and 38 mm length drug-eluting coronary stents in the U.S.

Three-year results from the TAXUS ATLAS Small Vessel Trial demonstrated a statistically significant reduction in the rate of Target Lesion Revascularization (TLR) in small vessels treated with the TAXUS Liberte Atom Stent as compared to the TAXUS Express Atom Stent (10.0% vs. 22.1%, p=0.008), representing a 55 percent relative risk reduction. Additionally, the three-year MACE rate for the TAXUS Liberte Atom Stent was 19.5 percent as compared to 32.4 percent for the TAXUS Express Atom Stent (p=0.03), a relative reduction of 40 percent. The composit
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Boston Scientific PROMUS(R) and First-Generation TAXUS(R) Express(R) Stents Continue Excellent Performance in SPIRIT III Trial
2. FDA Approves Boston Scientifics TAXUS(R) Liberte(R) Long Stent
3. SYNTAX Substudy Shows Positive Outcomes for Left Main Patients Treated With TAXUS(R) Express2(R) Stent System
4. Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System
5. TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program
6. TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
7. A consistent decline in heart attack rates following the implementation of smoking bans
8. Drug-eluting stents safe, effective for treatment of chronic total occlusions
9. Researchers find drug-eluting stents safe, effective for PCI in diabetics
10. New type of sirolimus-eluting stent demonstrates superior results
11. Sono-Tek Announces its Largest Ever Sales of MediCoat Stent Coating Systems to a Leading Global Medical Device Manufacturer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015 Today the National Resident Matching ... the 2015 Main Residency Match®. A record-number 30,212 ... filled when the matching algorithm was processed. Of ... the Match Week Supplemental Offer and Acceptance Program® (SOAP®) ... pleased with the outcome of the 2015 Main Residency ...
(Date:5/28/2015)... 28, 2015 Technology public relations ... (CNCK) as its agency of record to support ... app, SugarChecked. SugarChecked is an everyday grocery-shopping tool ... potential sugars they are putting in their bodies. ... of SugarChecked, execute media initiatives following launch, lead ...
(Date:5/28/2015)... May 28, 2015 Park Cities Pet Sitter ... Dog Training class starting Saturday, June 6th at 10:30am. ... of 5831 McCommas Blvd in Dallas, with a maximum of ... run for five weeks, with no class being held over ... is $135. , In this Intermediate-to-Advanced level class, dogs will ...
(Date:5/28/2015)... NJ (PRWEB) May 28, 2015 ... has announced an exclusive deal to patients looking to ... June 1 through 30, patients will be able to ... $800 procedure, for just $600. For a three-treatment package, ... fourth treatment at no cost. , Dr. Juanita Jenyons, ...
(Date:5/28/2015)... Melbourne, Florida (PRWEB) May 28, 2015 ... facial plastic surgeon , has hired Teresa Beard as ... Specialists. In her role, Beard will oversee all marketing ... 20 years of experience leading teams and developing compelling ... Clevens Face and Body Specialists, Beard served as guest ...
Breaking Medicine News(10 mins):Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3Health News:ContentChecked Selects PMBC Group To Launch New Nutrition App SugarChecked 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2
... , , MINNEAPOLIS, Aug. ... device company that develops, manufactures and markets innovative proprietary products to treat ... June 30, 2009. , , "Our team is successfully ... of growing U.S. Macroplastique sales and accumulating the clinical data for seeking ...
... , BIRMINGHAM, Ala., Aug. 3 ... Operating Income of $50.4 million, or $1.52 per diluted share for the ... or $1.62 per diluted share. For the six months ended June 30, ... Net Income was $82.2 million, or $2.46 per diluted share. , ...
... finds increases in use of other psychotropic medications , ... U.S. residents almost doubled between 1996 and 2005, along ... psychotropic medications, a new report shows. , The increase ... 10 percent of people over the age of 6 ...
... NEW YORK and EAST HAMPTON, N.Y., Aug. 3 Phoenix ... Artists & Writers 61st Annual Charity Softball Game will ... Hampton Day Care. , , This annual Hamptons rite ... Brinkley, Carl Bernstein, Mort Zuckerman, Lori Singer, B. Smith, Dan Gasby, Greg ...
... ST. LOUIS, Aug. 3 , , ... has recently completed its yearly survey of in-house physician recruiters on ... revealed that the physician shortage, coupled with the aging population, has ... fill openings. Survey results were compiled between May 1 and ...
... , , ALLEGAN, Mich., Aug. 3 ... that its partner Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ... U.S. Food and Drug Administration to market Triamcinolone Acetonide Nasal Spray ... applicant to file a complete ANDA with a Paragraph IV certification ...
Cached Medicine News:Health News:Uroplasty Reports First Fiscal Quarter Results 2Health News:Uroplasty Reports First Fiscal Quarter Results 3Health News:Uroplasty Reports First Fiscal Quarter Results 4Health News:Uroplasty Reports First Fiscal Quarter Results 5Health News:Uroplasty Reports First Fiscal Quarter Results 6Health News:Uroplasty Reports First Fiscal Quarter Results 7Health News:Uroplasty Reports First Fiscal Quarter Results 8Health News:Uroplasty Reports First Fiscal Quarter Results 9Health News:Uroplasty Reports First Fiscal Quarter Results 10Health News:Uroplasty Reports First Fiscal Quarter Results 11Health News:Uroplasty Reports First Fiscal Quarter Results 12Health News:Uroplasty Reports First Fiscal Quarter Results 13Health News:ProAssurance Reports Second Quarter 2009 Results 2Health News:ProAssurance Reports Second Quarter 2009 Results 3Health News:ProAssurance Reports Second Quarter 2009 Results 4Health News:ProAssurance Reports Second Quarter 2009 Results 5Health News:ProAssurance Reports Second Quarter 2009 Results 6Health News:ProAssurance Reports Second Quarter 2009 Results 7Health News:ProAssurance Reports Second Quarter 2009 Results 8Health News:ProAssurance Reports Second Quarter 2009 Results 9Health News:ProAssurance Reports Second Quarter 2009 Results 10Health News:ProAssurance Reports Second Quarter 2009 Results 11Health News:ProAssurance Reports Second Quarter 2009 Results 12Health News:ProAssurance Reports Second Quarter 2009 Results 13Health News:Antidepressant Use in U.S. Has Almost Doubled 2Health News:Antidepressant Use in U.S. Has Almost Doubled 3Health News:Hamptons' Artists & Writers 61st Annual Charity Softball Game To Benefit Phoenix House - To be Held at Herrick Park, East Hampton, Saturday, August 15, 2009, 3 pm 2Health News:Hamptons' Artists & Writers 61st Annual Charity Softball Game To Benefit Phoenix House - To be Held at Herrick Park, East Hampton, Saturday, August 15, 2009, 3 pm 3Health News:PracticeMatch Releases Results of Recent 'State of the Industry' Survey of Physician Recruiters 2Health News:Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ 2Health News:Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ 3
(Date:5/28/2015)... Texas , May 28, 2015   Lexicon ... that Lexicon management will present at the Jefferies 2015 ... a.m. Eastern Time in New York ... clinical development programs and milestones. A webcast ... at www.lexpharma.com . An archived version of the ...
(Date:5/28/2015)... DEKALB, Ill. , May 28, 2015 ... Intent to explore an affiliation with Northwestern Memorial ... and NMHC will further define the affiliation, which ... "KishHealth is recognized for their commitment to ... Dean M. Harrison , President and Chief Executive ...
(Date:5/28/2015)... MONICA, Calif. , May 28, 2015 ... doctors to check a state prescription database before prescribing ... addiction and thousands of overdose deaths. SB ... Bell Gardens , will require prescribers to ... (CURES) before prescribing Schedule II and III drugs, like ...
Breaking Medicine Technology:Lexicon To Present At The Jefferies 2015 Healthcare Conference 2KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 2KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 3California Senate Approves Legislation Requiring Physicians To Check State Database Before Prescribing Powerful, Addictive Medications, Says Consumer Watchdog 2
... Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: ... specializing in the development, manufacturing, and marketing of ... that Shanghai Celgen Bio-Pharmaceutical Co., Ltd. ("Shanghai Celgen") ... interest, has received new drug registration approval for ...
... Cempra Pharmaceuticals, a developer of differentiated antibiotics, ... (IV) solithromycin demonstrates excellent tolerability and ... up to 800 mg.  Oral administration of solithromycin ... 1 studies.  The presentation will be at the ...
Cached Medicine Technology:Simcere Announces Recent Progress of Qiangke's Registration 2Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 2Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 3Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 4Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 5Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 6Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial 7
An economical solution to the need to provide wrap-around protection. The one-sided velcro closure allows greater flexibility in sizing. Front protection is 0.5mm Pb and the back is 0.25mm Pb equival...
This wrap around apron features a uniquely designed orthopedic wide belt that is integrated directly on the apron....
The most comfortable and easy to use apron in the industry. This front protection apron comes with a fully adjustable snap-on 5" orthopedic belt to relieve weight off your shoulders. Velcro strap acr...
Unique criss-cross strapping. The MSV-10 is our most popular model. Extra wide Velcro ensures a wide variety of adjustments and easy closing....
Medicine Products: